Clinical Trials on Psychostimulant Dependence in United States

Total 1386 results

Eagle Pharmaceuticals, Inc.

Terminated

Efficacy and Safety Study of Ryanodex as Adjuvant Treatment in Subjects With Psychostimulant Drug-Induced Toxicity (PDIT)

Drug Toxicity Psychotropic Agents Psychostimulants

United States
Yale University
National Institute on Drug Abuse (NIDA)

Completed

Disulfiram for Cocaine Abuse in Buprenorphine Treatment

Opioid Dependency | Cocaine Dependence

United States
Yale University
National Institute on Drug Abuse (NIDA)

Completed

Efficacy of Levetiracetam in Cocaine-Abusing Methadone Maintained Patients (Keppra-DB)

Opioid Dependency | Cocaine Dependence

United States
Medical University of South Carolina
National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Completed

Cortical rTMS as a Tool to Change Brain Reactivity to Alcohol Cues (ARC4)

Alcohol Dependance

United States
University of California, Los Angeles

Completed

Optimizing Outcomes Using Suboxone for Opiate Dependence (OpBup)

Opioid Dependency

United States
Titan Pharmaceuticals

Terminated

Study of Probuphine in Patients With Opioid Dependence (PRO-809)

Opioid Dependency

United States
Duke University

Completed

An Opioid Prescribing Nudge (OHS)

Health Behavior | Opioid Use, Unspecified | Benzodiazepine Abuse | Prescription Drug Abuse (Not Dependent) | Benzodiazepine Dependent | Prescription Drug Abuse and Dependency

United States
University of Chicago

Completed

N-Acetyl Cysteine Plus Naltrexone in Methamphetamine Dependence

Methamphetamine Dependence

United States
New York State Psychiatric Institute

Terminated

Gabapentin Treatment of Benzodiazepine Dependence

Benzodiazepine Dependence

United States
Oregon Health and Science University
Portland VA Medical Center

Completed

Effects of Genotype on Resting State Connectivity During Methamphetamine Administration (MATAAR)

Methamphetamine-dependence

United States
Oregon Health and Science University
Portland VA Medical Center

Completed

Pilot Study of Entacapone for Methamphetamine Abuse

Methamphetamine Dependence

United States
Seattle Institute for Biomedical and Clinical Research
Janssen, LP

Completed

A Trial of Long-Acting Injectable Risperidone in the Treatment of Methamphetamine Dependence

Methamphetamine Dependence

United States
Yale University
National Institute on Drug Abuse (NIDA)

Completed

Chronic Pain and Opioid Dependence Assessment and Treatment (CPODAT)

Chronic Pain | Opioid Dependency

United States
Public Health Institute, California

Completed

Intensive Motivational Interviewing for Methamphetamine Dependence

Methamphetamine Dependence

United States
Medical University of South Carolina
National Institute on Drug Abuse (NIDA); National Institutes of Health (NIH)

Completed

Transcranial Magnetic Stimulation Used to Both Measure Cortical Excitability and Explore Methamphetamine Cue Craving

Methamphetamine Dependence

United States
University of Arkansas
National Institute on Drug Abuse (NIDA)

Completed

Clinical Efficacy of Lisdexamfetamine for Methamphetamine Dependence

Methamphetamine Dependence

United States
California Pacific Medical Center Research Institute
Creare, Inc.

Unknown

Comparison of Methamphetamine-Dependent and Healthy Volunteers Using a Web-Enabled Cognitive Neuropsychological Evaluation System (5I)

Methamphetamine Dependence

United States
University of Arkansas

Completed

Open-Label Disulfiram for Methamphetamine Dependence

Methamphetamine Dependence

United States
University of Arkansas
National Institute on Drug Abuse (NIDA)

Completed

Safety and Tolerability of Modafinil for Methamphetamine Dependence

Methamphetamine Dependence

United States
University of Arkansas

Terminated

Methamphetamine-Quetiapine Interactions in Humans

Methamphetamine Dependence

United States
University of Arkansas

Terminated

Modafinil for Methamphetamine Dependence

Methamphetamine Dependence

United States
National Institute on Drug Abuse (NIDA)

Completed

Phase 1 Naltrexone-Bupropion-Methamphetamine Interaction Study

Methamphetamine Dependence

United States
National Institute on Drug Abuse (NIDA)

Unknown

Tolerability and Safety of 30, 45, and 60 mg of Sublingual Lobeline. - 1

Methamphetamine Dependence

United States
University of Arkansas

Completed

Studying Amphetamine Withdrawal in Humans

Methamphetamine Dependence

United States
University of California, Los Angeles

Unknown

Methylphenidate to Treat Methamphetamine Dependence (MPH)

Methamphetamine Dependence

United States
University of Nebraska

Completed

Risk and Protective Factors for Rural Methamphetamine Dependence

Methamphetamine Dependence

United States
University of Kentucky
National Institute on Drug Abuse (NIDA)

Completed

Buspirone as a Candidate Medication for Methamphetamine Abuse

Methamphetamine Dependence | Methamphetamine Abuse

United States
University of Kentucky
National Institute on Drug Abuse (NIDA)

Completed

Targeting GABA and Opioid Systems for a Pharmacotherapy for Methamphetamine Abuse

Methamphetamine Dependence | Methamphetamine Abuse

United States
University of Arkansas

Completed

Characterizing Methamphetamine Withdrawal in Recently Abstinent Methamphetamine Users: A Pilot Study

Methamphetamine Dependence | Methamphetamine Withdrawal

United States
University of California, Los Angeles
National Institute on Drug Abuse (NIDA)

Terminated

Safety Assessment of Atomoxetine With MA IV Administration

Methamphetamine Dependence | Methamphetamine Abuse

United States
University of Cincinnati
National Institute on Drug Abuse (NIDA); Maryhaven

Unknown

Community Reinforcement and Family Training for Drug Abuse Treatment Retention/HIV Risk Reduction

Heroin Dependence | Opiate Dependence | Substance Dependence

United States
University of Cincinnati
National Institute on Drug Abuse (NIDA)

Completed

An Eval of Neurocognitive Function, Oxidative Damage, and Their Association With Outcomes in METH and Cocaine Abusers.

Stimulant Dependence

United States
University of Cincinnati
National Institute on Drug Abuse (NIDA)

Completed

Safety Assessment of Potential Interactions Between IV Methamphetamine and Osmotic-Release Methylphenidate (OROS-MPH)

Methamphetamine Dependence | Methamphetamine Abuse

United States, Canada
University of Utah

Recruiting

PRevention Of Methamphetamine Use Among Postpartum Women Trial (PROMPT)

Methamphetamine-dependence | Postpartum Abstinence

United States
University of California, San Francisco

Completed

Intranasal Oxytocin and Social Cognition, Implicit Preferences and Craving in Alcohol Drinkers

AOD Use, Abuse, and Dependence

United States
University of Southern California
National Institute on Drug Abuse (NIDA); University of Toronto; RTI International

Completed

Change the Cycle: An RCT to Prevent Injection Initiation (CTC)

Substance Abuse, Intravenous | HIV | Heroin Dependence | Opioid Dependence | Cocaine Dependence | Amphetamine Dependence

United States
Madhukar H. Trivedi, MD

Terminated

Monthly Injectable BUP for MA Use Disorder (MURB) Trial (CTN-0110)

Methamphetamine-dependence

United States
InterveXion Therapeutics, LLC
National Institute on Drug Abuse (NIDA)

Completed

Study of Antibody for Methamphetamine Outpatient Therapy (STAMPOUT)

Methamphetamine-dependence | Methamphetamine Abuse

United States
Mclean Hospital
National Institute on Drug Abuse (NIDA)

Completed

Nabilone for Cannabis Dependence: A Pilot Study (NAB CAN)

Cannabis Dependence | Marijuana Dependence

United States
University of South Florida

Recruiting

Opioid Free Anesthesia vs. Opioid Anesthesia Techniques. (OFA vs OA)

Colectomy | Analgesic Drug Dependence

United States
Mclean Hospital
Harvard Medical School (HMS and HSDM)

Completed

Transdermal Electroacupuncture for Opioid Detoxification

Opioid Dependency

United States
University of Virginia
National Institute on Drug Abuse (NIDA)

Completed

Medications Development for the Treatment of Cannabis Related Disorders (MTC)

Cannabis Dependence | Nicotine Dependence | Marijuana Dependence | Cannabis Abuse | Nicotine Withdrawal

United States
GlaxoSmithKline

Completed

Provoked Craving Assessment

Smoking | Smoking Dependence

United States
National Institute on Drug Abuse (NIDA)

Unknown

Ph1 Lobeline Interaction Study - 1

Methamphetamine Dependence

United States
University of Pennsylvania

Completed

Effectiveness of Extended Treatment for Drug Dependence (ETDD) in the City Study

Cocaine Dependence

United States
National Institute on Drug Abuse (NIDA)
VA Office of Research and Development

Completed

Phase 2, Multi-Center Trial of Modafinil for Methamphetamine Dependence

Methamphetamine Dependence

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Completed

Combined Pharmacotherapy for Cannabis Dependency (D-LUCS)

Cannabis Dependence | Marijuana Dependence

United States
University of Wisconsin, Madison

Completed

Stress Neuroadaptation in Tobacco Dependence

Nicotine Dependence

United States
University of Pennsylvania
National Institute on Drug Abuse (NIDA)

Completed

Effectiveness of Extended Treatments for Drug Dependence (ETDD)

Cocaine Dependence

United States
Catalyst Pharmaceuticals, Inc.

Completed

A Safety, Tolerability and Pharmacokinetic Study of CPP-115

Cocaine Dependency

United States

Clinical Trials on Psychostimulant Dependence in United States

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Myanmar

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations